StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report issued on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Performance
Shares of NASDAQ AEZS opened at $3.70 on Tuesday. The business’s 50 day moving average price is $4.42 and its 200-day moving average price is $6.11. Aeterna Zentaris has a fifty-two week low of $3.96 and a fifty-two week high of $12.00. The company has a market cap of $6.63 million, a price-to-earnings ratio of -0.25 and a beta of 1.55.
About Aeterna Zentaris
Featured Stories
- Five stocks we like better than Aeterna Zentaris
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- What is the FTSE 100 index?
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- What to Know About Investing in Penny Stocks
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.